Clinical Edge Journal Scan

Clinical Edge Journal Scan

Study supports long-term benefits of galcanezumab in episodic migraine

Publish date: August 19, 2023

Read More

Clinical Edge Journal Scan

CGRP mAb can be used for migraine prevention in veterans at risk for COVID-19

Publish date: August 19, 2023

Read More

Clinical Edge Journal Scan

Benefits of atogepant extended to chronic migraine

Publish date: August 19, 2023

Read More

Clinical Edge Journal Scan

Commentary: Vasodilation, antihypertensive drugs, and caffeine in migraine, August 2023

Author:: Thomas Berk, MD

Publish date: August 9, 2023

Read More

Clinical Edge Journal Scan

Switch from anti-CGRP receptor to anti-CGRP ligand mAb offers promise in treatment-refractory chronic migraine

Publish date: July 22, 2023

Read More

Clinical Edge Journal Scan

Monthly or quarterly fremanezumab shows favorable efficacy and tolerability in migraine

Publish date: July 22, 2023

Read More

Clinical Edge Journal Scan

Higher dietary caffeine intake tied to severe headaches or migraines

Publish date: July 22, 2023

Read More

Clinical Edge Journal Scan

Long-term erenumab shows sustained efficacy and safety in chronic migraine

Publish date: July 22, 2023

Read More

Clinical Edge Journal Scan

Ultrasound-guided stellate ganglion block: A safe and effective option for treating migraine in elderly

Publish date: July 22, 2023

Read More

Clinical Edge Journal Scan

Decrease in visual hypersensitivity predicts clinical response to anti-CGRP mAbs in migraine

Publish date: July 22, 2023

Read More

Pages

Menu Close